Jan 24 UK vaccination drive expands as virus toll nears 100,000 By Jill Lawless, Associated Press Health Secretary Matt Hancock said Sunday that three-quarters of the U.K.’s over-80s have received a vaccine shot. He said three-quarters of nursing home residents have also had their first jab. Continue reading
Jan 04 UK first in world to start using Oxford-AstraZeneca vaccine By Danica Kirka, Associated Press The COVID-19 vaccine ramps up a nationwide inoculation program, as rising infection rates are putting an unprecedented strain on British hospitals. Continue reading
Dec 30 U.K. approves use of ‘vaccine for the world’ By Danica Kirka, Mike Corder, Associated Press Britain has authorized an easy-to-handle coronavirus vaccine and decided to stretch out the time between doses to allow more people to get some level of protection faster as infections surge. Continue reading
Oct 23 AstraZeneca, Johnson & Johnson resume U.S. tests of COVID-19 vaccines By Linda A. Johnson, Associated Press Two drugmakers say they have the go-ahead to resuming U.S. testing of their COVID-19 vaccine candidates. Both are in the final stage of testing before the companies can seek regulatory approval. Continue reading
Sep 15 FDA weighs whether to resume AstraZeneca vaccine trials after patient’s serious side effect By Arthur Allen, Liz Szabo, Kaiser Health News The Food and Drug Administration is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as the National Institutes of Health has launched an investigation of… Continue reading
Sep 12 Oxford and AstraZeneca resume coronavirus vaccine trial By Pan Pylas, Associated Press The vaccine being developed by Oxford and AstraZeneca is widely perceived to be one of the strongest contenders among the dozens of coronavirus vaccines in various stages of testing around the world. Continue reading
Sep 08 AstraZeneca COVID-19 vaccine study paused after one illness By Lauren Neergaard "This is not something to be alarmed about," Fuller said. Instead, it's reassuring that the company is pausing the study to figure out what's happening and carefully monitoring the health of study participants. Continue reading
May 03 Watch Pfizer-AstraZeneca deal could impact drug development By PBS News Hour Pfizer made a $106 billion bid for the British drug maker AstraZeneca this week in a move that was potentially motivated by lower corporate tax rates overseas. The deal could also affect the development of new drugs. Hari Sreenivasan speaks… Continue watching